Universal Health Realty Income Trust (UHT) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
27 Jul, 2026Executive summary
Net income for Q2 2026 was $5.9 million ($0.43 per diluted share), up from $4.5 million ($0.32 per diluted share) in Q2 2025, including a $724,000 gain on land sale.
Adjusted net income for Q2 2026 was $5.2 million ($0.37 per diluted share), up $691,000 year-over-year.
For the first half of 2026, net income was $10.9 million ($0.79 per diluted share), compared to $9.3 million ($0.67 per diluted share) in 2025.
Financial highlights
Q2 2026 funds from operations (FFO) were $12.5 million ($0.90 per diluted share), up from $11.8 million ($0.85 per diluted share) in Q2 2025.
Six-month FFO was $24.8 million ($1.79 per diluted share), up from $23.7 million ($1.71 per diluted share) year-over-year.
Dividend of $0.75 per share ($10.4 million total) declared and paid in Q2 2026.
Revenues for Q2 2026 were $25.0 million, nearly flat year-over-year.
Outlook and guidance
Construction of Miller Medical Plaza, an 80,000 sq. ft. medical office building, began in February 2026 and is expected to complete in December 2026 at a cost of $34 million.
A 10-year master flex lease for 75% of the new building's rentable space has been executed.
Latest events from Universal Health Realty Income Trust
- Trustee elections, executive pay, and auditor ratification all passed with no shareholder questions.UHT
AGM 202622 Jun 2026 - Trustees, executive pay, and auditor were approved by shareholders in a virtual meeting.UHT
AGM 202522 Jun 2026 - All proposals, including trustee elections and auditor ratification, were approved by shareholders.UHT
AGM 202421 Jun 2026 - Q2 and H1 2024 net income and FFO rose, with higher dividends and ongoing industry risks.UHT
Q2 202417 Jun 2026 - Net income, revenues, and FFO rose, with higher interest costs and expanded credit capacity.UHT
Q3 202417 Jun 2026 - Net income and FFO rose year-over-year, supported by property income and prudent capital actions.UHT
Q4 202417 Jun 2026 - Raised 2025 guidance after strong Q2 results and incremental Medicaid reimbursements.UHT
Q2 202517 Jun 2026 - Net income and FFO dipped, with new development underway and higher borrowing costs noted.UHT
Q4 202517 Jun 2026 - Mixed earnings and revenue trends, with stable liquidity but ongoing regulatory and litigation risks.UHT
Q1 202517 Jun 2026